Expertise in
2
conditions

Dr. David C. Robbins

Endocrinology
University Of Kansas Hospital Transplant Center
3901 Rainbow Blvd, 
Kansas City, KS 
Accepting New Patients
Referral required
Before you request
Expertise in
2
conditions
University Of Kansas Hospital Transplant Center
3901 Rainbow Blvd, 
Kansas City, KS 

Overview

David Robbins is an Endocrinologist practicing medicine in Kansas City, Kansas.

Dr. Robbins is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Sotos Syndrome, and Acromegaly.

He is actively involved in clinical research, co-authoring 20 peer reviewed articles and participating in 4 clinical trials. Dr. Robbins is currently accepting new patients.

Specialties

Endocrinology

Licenses

Specialist in KS

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

University of Kansas Hospital Transplant Center
3901 Rainbow Blvd, Kansas City, KS 66160

Additional Areas of Focus

Dr. Robbins has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
mHealth Insulin Titration and Management (iSage)
mHealth Insulin Titration and Management (iSage)
Enrollment Status: Completed
Publish Date: August 08, 2023
Intervention Type: Other
Study Phase: Not Applicable
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
Enrollment Status: Completed
Publish Date: May 01, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D
Enrollment Status: Completed
Publish Date: March 27, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

20 Total Publications

Electronic Monitoring of Mom's Schedule (eMOMS™): A Feasibility Randomized Controlled Trial Targeting Postpartum Weight Retention and Breastfeeding Duration Among Populations With Overweight/Obesity.
Electronic Monitoring of Mom's Schedule (eMOMS™): A Feasibility Randomized Controlled Trial Targeting Postpartum Weight Retention and Breastfeeding Duration Among Populations With Overweight/Obesity.
Journal: Journal of human lactation : official journal of International Lactation Consultant Association
Published: November 26, 2024
Similar Doctors
Expertise in
24
conditions
Expertise in
24
conditions
Referral required
Before you request

Medical Pavilion

2000 Olathe Boulevard, 
Kansas City, KS 
 (0.3 miles away)
913-588-1227
Languages Spoken:
English, Mandarin, Thai
See accepted insurances
Accepting New Patients
Offers Telehealth

Rudruidee Karnchanasorn is an Endocrinologist practicing medicine in Kansas City, Kansas. Dr. Karnchanasorn is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Anaplastic Thyroid Cancer, Thyroid Nodule, and Secondary Adrenal Insufficiency. Dr. Karnchanasorn is board certified in American Board Of Internal Medicine, Endocrinology Diabetes And Metabolism - 2011. Dr. Karnchanasorn is currently accepting new patients.

Expertise in
60
conditions
Dr. Michael S. Sokol
Endocrinology
Expertise in
60
conditions
Dr. Michael S. Sokol
Endocrinology
Referral required
Before you request

Statland Medical Group

12140 Nall Ave Ste 100, 
Overland Park, KS 
 (11.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Sokol is an Endocrinologist practicing medicine in Overland Park, Kansas. Dr. Sokol is highly rated in 60 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Hyperparathyroidism, Osteoporosis, and Postmenopausal Osteoporosis. Dr. Sokol is currently accepting new patients.

Expertise in
32
conditions
Dr. Chitra Choudhary
Endocrinology
Expertise in
32
conditions
Dr. Chitra Choudhary
Endocrinology
Referral required

The University Of Kansas Hospital

4000 Cambridge Street, 
Kansas City, KS 
 (0.2 miles away)
913-588-1227
Experience:
17+ years
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Chitra Choudhary is an Endocrinologist practicing medicine in Kansas City, Kansas. She has been practicing medicine for over 17 years. Dr. Choudhary is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Hyperthyroidism, Thyroid Storm, Peripheral Neuropathy, and Thyroid Cancer. Dr. Choudhary is board certified in American Board Of Internal Medicine, Endocrinology Diabetes And Metabolism - 2016 and American Board Of Internal Medicine, Internal Medicine - 2014. Dr. Choudhary is currently accepting new patients.

Frequently Asked Questions about Dr. David C. Robbins

How do I make an appointment with Dr. David C. Robbins?

You can book an appointment with Dr. David C. Robbins by calling their office at 913-588-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David C. Robbins a top-rated expert for Type 2 Diabetes (T2D)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David C. Robbins is classified as an Advanced expert for Type 2 Diabetes (T2D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David C. Robbins specialize in?

While Dr. David C. Robbins is a Endocrinology, they have specific expertise in Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Sotos Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. David C. Robbins participate in research or clinical trials?

Yes. Dr. David C. Robbins has published 20 articles and abstracts on conditions like Type 2 Diabetes (T2D). You can view a list of Dr. David C. Robbins's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David C. Robbins accept my insurance?

Dr. David C. Robbins accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 913-588-5000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Robbins's expertise for a condition
ConditionClose
      View All 35 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile